Targeted combination immunotherapy
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 27, 2007
Grant Date -
Dec 18, 2003
app pub date -
Feb 10, 2003
filing date -
May 3, 1996
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention is directed to methods for treating cancer wherein more than one therapeutic agent is used, with each of the therapeutic agents having different tumor-killing capabilities, and wherein the therapeutic agents are delivered to the tumor sites using combined targeting and pre-targeting methods. The methods of the present invention achieve good tumor to non-tumor ratios of the therapeutic agents, and are effective for cancer therapy.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully